Pulse.

a daily field guide to health research that matters

◆ Console

‹ Mon · 2 Nov 2026
Near-term implementable finding

Intraoperative artificial intelligence for brain tumor surgery: from tissue diagnosis to real-time surgical guidance

Surgeons can now learn tumor type and molecular features in real-time during brain surgery instead of waiting days, enabling better immediate surgical decisions.

This study validated an intraoperative AI that provides real-time molecular classification of gliomas including IDH status and methylation class during surgery, information that previously required days to weeks post-operatively. The advance directly enables intraoperative surgical decision-making aligned with WHO 2021 molecular glioma classification, representing a paradigm shift in neurosurgical oncology.

What the study was

Study design
Prospective clinical validation study
Population
Glioma patients undergoing surgical resection
Category
Diagnostics
Maturity
Validated
Journal
Neurosurgical focus

Why it surfaced

Real-time intraoperative molecular AI for glioma; transforms surgical oncology workflow by delivering actionable molecular information during rather than after surgery.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.